McKesson Stock Rises on Q2 Earnings Beat and Dividend Hike

Key Facts

In a move reflecting strong operational performance within the healthcare sector, McKesson reported robust fiscal results that exceeded analyst estimates on both top and bottom lines. The company posted earnings per share of $9.93, beating expectations, while revenue reached $105.38 billion, representing a 7.7% increase compared to the previous year. According to reports, these results have bolstered investor confidence in the company's ability to generate sustainable cash flows.

The positive earnings were accompanied by management's decision to raise the quarterly dividend to $0.94 per share, underscoring a commitment to enhancing shareholder returns. Per market data, the stock has shown a steady upward trend, trading near the upper end of its recent range. The company's fiscal 2027 guidance, targeting EPS between $44.20 and $45.00, reflects optimism in sustaining profit growth beyond current market estimates.

McKesson stock (0JZU.L) stood at $862.41 at the close of August 21, 2026, after reaching a day high of $865.6. Traders are currently monitoring resistance levels near the daily peak, while attention remains on broader US economic data, including Pending Home Sales and machinery orders, to gauge overall market momentum in the absence of further direct corporate catalysts in the coming days.